“Global Laboratory Information Systems market set to grow to $2.8bn by 2023” says new Visiongain report

19 November 2018
Pharma

Visiongain has launched a new pharma report: Global Laboratory Information Systems Market Forecast 2018-2028: Web-Based, On-Premise Based, Cloud-Based, Software, Hardware, Services, Clinical, Drug Discovery, Industrial.

The laboratory information system ("LIS") industry includes set of programs and hardware, which are part of an integrated system designed for healthcare information. It is an information system intended for capturing complex data and information related to medical and industrial laboratories, including clinical and analytical laboratories. The information system interfaces with analytical instruments and allows users to obtain, store, manage, retrieve and record laboratory data. As industrial and medical laboratories are diverse with different requirements; hence, there is no standard information system designed for laboratories. Therefore, a laboratory information system is customized, developed, and configured according to the requirements of a laboratory.

The lead analyst of the report commented "The global LIS market is currently fragmented in most countries, but few large vendors hold significant market shares. However, many new players are entering the market and the consolidation of small players with larger counterparts is shaping the vendor landscape. Competition is getting intense and key players are trying to sustain themselves by improving their delivery models with increased usage of technology."

Leading companies featured in the report include Abbott Laboratories, Cerner Corporation, Eclipsys Corporation, LabVantage Solutions, Inc., LabWare, Inc., McKesson Corporation, Medical Information Technology, Inc., Thermo Fisher Scientific

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

Read

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

Read

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

Read

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever